Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor
Abroad (travel likely)RecruitingPHASE3
Conditions
Intradialytic Hypotension
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vanderbilt Fresenius, Nashville, Tennessee, United States
Study leads
Jorge L Gamboa, MD/PhD
Principal Investigator
Vanderbilt University Medical Center
Peter Kotanko, MD, FASN
Principal Investigator
Renal Research Institute
Talat A Ikizler, MD
Principal Investigator
Vanderbilt University Medical Center